Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» tivozanib
tivozanib
Aveo Pharmaceuticals: A Hidden Gem Or A Hidden Disaster
Seeking Alpha
Mon, 12/10/12 - 12:30 pm
Aveo Pharmaceutical
tivozanib
Pfizer
ONYX Pharmaceuticals
Novartis
GSK
Eli Lilly
Exelixis
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
AVEO: More Open Questions Than Answers
Seeking Alpha
Sun, 01/8/12 - 12:47 pm
Aveo Pharmaceutical
tivozanib
kidney cancer
renal cancer
Aveo Shares Decline Early After Cancer Data Misses Investor Expectations
Bloomberg
Tue, 01/3/12 - 11:31 am
Aveo Pharmaceutical
Astellas
renal cell carcinoma
tivozanib
A Quick Roundup Of The New Drugs Presented At This Weekend's Huge Oncology Conference
Yahoo/Business Insider
Mon, 06/6/11 - 10:25 am
ASCO
Amgen
Aveo Pharmaceutical
Celgene
Medivation
tivozanib
abiraterone
Abraxane
AMG 479
Revlimid
10 promising late-stage cancer drugs
Fierce Biotech
Tue, 04/5/11 - 10:47 pm
cancer
Carfilzomib
crizotinib
vismodegib
Oncovex
PLX4032
Ponatinib
SGN-35
tivozanib
T-DM1
cabozantinib
ONYX Pharmaceuticals
Pfizer
Genentech
Curis
Amgen
Plexxikon
Seattle Genetics
Ariad Pharmaceuticals
Aveo Pharmaceutical
Exelixis
Roche
Aveo Pharma, Astellas in $1.3B cancer drug deal
Yahoo/AP
Thu, 02/17/11 - 09:01 am
Aveo Pharmaceutical
Astellas
cancer
tivozanib
Pfizer
ONYX Pharmaceuticals
3 Biotech 2010 IPOs Worthy of a Look
Motley Fool
Sun, 01/2/11 - 11:34 am
biotech
Pacific Biosciences
Alimera
Aveo Pharmaceutical
Biogen Idec
tivozanib
kidney cancer
DNA sequencing
Pages
« first
‹ previous
1
2
3